Bio Retained Earnings from 2010 to 2025

TECH Stock

USD 55.31 2.19 4.12%

Bio Techne's Retained Earnings are increasing with slightly volatile movements from year to year. Retained Earnings are estimated to finish at about 1.6 B this year. Retained Earnings is the cumulative amount of net income that Bio Techne Corp retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

1989-09-30

Previous Quarter

1.3 B

Current Value

1.2 B

Quarterly Volatility

418.8 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.9 M, Total Revenue of 1.4 B or Gross Profit of 929.4 M, as well as many indicators such as Price To Sales Ratio of 6.9, Dividend Yield of 0.0049 or PTB Ratio of 6.78. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.

Build AI portfolio with Bio Stock

Check out the analysis of Bio Techne Correlation against competitors.

Latest Bio Techne's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Bio Techne Corp over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Bio Techne's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.33 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Bio Retained Earnings Regression Statistics

	Arithmetic Mean	929,967,363
	Geometric Mean	608,398,868
	Coefficient Of Variation	43.87
	Mean Deviation	314,628,113
	Median	931,934,000
	Standard Deviation	407,982,233
	Sample Variance	166449.5T
	Range	1.6B
	R-Value	0.97
	Mean Square Error	11725T
	R-Squared	0.93
	Slope	82,828,525
	Total Sum of Squares	2496742.5T

Bio Retained Earnings History

	2025	1.6 B
	2024	1.5 B
	2023	1.3 B
	2022	1.3 B
	2021	1.1 B
	2020	1.1 B
	2019	1.1 B

Other Fundumenentals of Bio Techne Corp

Retained Earnings Total Equity

Bio Techne Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.76	0.98	0.98	0.91	0.9	0.85	0.73	0.9	-0.46	0.8	0.81	0.76	0.98	0.92	0.14	0.94	0.72	0.69	-0.03	0.78	0.22	0.9	0.77
Total Stockholder Equity	0.98		0.65	0.99	0.98	0.82	0.93	0.83	0.71	0.82	-0.46	0.85	0.7	0.73	0.94	0.9	0.29	0.96	0.61	0.68	-0.07	0.67	0.24	0.89	0.83
Net Debt	0.76	0.65		0.68	0.72	0.92	0.44	0.58	0.6	0.89	-0.42	0.47	0.94	0.55	0.84	0.79	-0.35	0.64	0.78	0.56	0.1	0.9	0.22	0.67	0.46
Retained Earnings	0.98	0.99	0.68		0.96	0.86	0.93	0.81	0.73	0.86	-0.41	0.8	0.74	0.73	0.95	0.87	0.18	0.91	0.66	0.6	-0.02	0.7	0.24	0.85	0.76
Net Receivables	0.98	0.98	0.72	0.96		0.85	0.87	0.78	0.73	0.84	-0.56	0.86	0.75	0.67	0.96	0.94	0.25	0.96	0.67	0.65	-0.03	0.72	0.28	0.88	0.84
Total Liab	0.91	0.82	0.92	0.86	0.85		0.71	0.77	0.69	0.98	-0.42	0.56	0.97	0.74	0.95	0.86	-0.25	0.78	0.88	0.63	0.07	0.93	0.13	0.79	0.53
Total Current Assets	0.9	0.93	0.44	0.93	0.87	0.71		0.82	0.62	0.69	-0.22	0.75	0.59	0.71	0.81	0.72	0.31	0.86	0.55	0.64	-0.05	0.59	0.18	0.82	0.71
Short Term Debt	0.85	0.83	0.58	0.81	0.78	0.77	0.82		0.56	0.77	-0.25	0.52	0.63	0.89	0.83	0.82	0.12	0.87	0.63	0.81	-0.14	0.6	-0.04	0.86	0.5
Accounts Payable	0.73	0.71	0.6	0.73	0.73	0.69	0.62	0.56		0.71	-0.43	0.53	0.65	0.52	0.75	0.7	-0.02	0.64	0.61	0.24	0.62	0.61	0.23	0.66	0.5
Intangible Assets	0.9	0.82	0.89	0.86	0.84	0.98	0.69	0.77	0.71		-0.45	0.51	0.93	0.77	0.95	0.85	-0.27	0.76	0.85	0.56	0.08	0.88	0.07	0.76	0.48
Short Term Investments	-0.46	-0.46	-0.42	-0.41	-0.56	-0.42	-0.22	-0.25	-0.43	-0.45		-0.57	-0.38	-0.21	-0.54	-0.64	-0.2	-0.53	-0.36	-0.17	0.01	-0.33	-0.19	-0.42	-0.59
Common Stock	0.8	0.85	0.47	0.8	0.86	0.56	0.75	0.52	0.53	0.51	-0.57		0.47	0.36	0.73	0.77	0.58	0.85	0.32	0.56	-0.13	0.46	0.44	0.76	1.0
Long Term Debt	0.81	0.7	0.94	0.74	0.75	0.97	0.59	0.63	0.65	0.93	-0.38	0.47		0.6	0.86	0.75	-0.38	0.66	0.86	0.56	0.18	0.98	0.19	0.7	0.44
Property Plant Equipment	0.76	0.73	0.55	0.73	0.67	0.74	0.71	0.89	0.52	0.77	-0.21	0.36	0.6		0.75	0.71	-0.03	0.72	0.71	0.61	-0.08	0.61	-0.21	0.81	0.33
Good Will	0.98	0.94	0.84	0.95	0.96	0.95	0.81	0.83	0.75	0.95	-0.54	0.73	0.86	0.75		0.95	0.01	0.91	0.77	0.65	0.01	0.82	0.22	0.87	0.71
Current Deferred Revenue	0.92	0.9	0.79	0.87	0.94	0.86	0.72	0.82	0.7	0.85	-0.64	0.77	0.75	0.71	0.95		0.17	0.95	0.68	0.7	-0.06	0.7	0.19	0.89	0.77
Net Tangible Assets	0.14	0.29	-0.35	0.18	0.25	-0.25	0.31	0.12	-0.02	-0.27	-0.2	0.58	-0.38	-0.03	0.01	0.17		0.37	-0.33	0.23	-0.29	-0.36	0.16	0.27	0.6
Capital Surpluse	0.94	0.96	0.64	0.91	0.96	0.78	0.86	0.87	0.64	0.76	-0.53	0.85	0.66	0.72	0.91	0.95	0.37		0.58	0.79	-0.13	0.63	0.17	0.94	0.84
Deferred Long Term Liab	0.72	0.61	0.78	0.66	0.67	0.88	0.55	0.63	0.61	0.85	-0.36	0.32	0.86	0.71	0.77	0.68	-0.33	0.58		0.41	0.14	0.86	0.01	0.65	0.3
Long Term Investments	0.69	0.68	0.56	0.6	0.65	0.63	0.64	0.81	0.24	0.56	-0.17	0.56	0.56	0.61	0.65	0.7	0.23	0.79	0.41		-0.34	0.59	0.09	0.78	0.56
Short Long Term Debt	-0.03	-0.07	0.1	-0.02	-0.03	0.07	-0.05	-0.14	0.62	0.08	0.01	-0.13	0.18	-0.08	0.01	-0.06	-0.29	-0.13	0.14	-0.34		0.18	0.03	0.01	-0.13
Long Term Debt Total	0.78	0.67	0.9	0.7	0.72	0.93	0.59	0.6	0.61	0.88	-0.33	0.46	0.98	0.61	0.82	0.7	-0.36	0.63	0.86	0.59	0.18		0.21	0.71	0.44
Net Invested Capital	0.22	0.24	0.22	0.24	0.28	0.13	0.18	-0.04	0.23	0.07	-0.19	0.44	0.19	-0.21	0.22	0.19	0.16	0.17	0.01	0.09	0.03	0.21		0.12	0.45
Net Working Capital	0.9	0.89	0.67	0.85	0.88	0.79	0.82	0.86	0.66	0.76	-0.42	0.76	0.7	0.81	0.87	0.89	0.27	0.94	0.65	0.78	0.01	0.71	0.12		0.74
Capital Stock	0.77	0.83	0.46	0.76	0.84	0.53	0.71	0.5	0.5	0.48	-0.59	1.0	0.44	0.33	0.71	0.77	0.6	0.84	0.3	0.56	-0.13	0.44	0.45	0.74

Click cells to compare fundamentals

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's Retained Earnings, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Retained Earnings	1.5 B	1.6 B
Retained Earnings Total Equity	1.5 B	812.3 M

Currently Active Assets on Macroaxis

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A
DD	Dupont De Nemours
GM	General Motors

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Techne's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Bio Techne Correlation against competitors.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.55)

Dividend Share

0.32

Earnings Share

0.83

Revenue Per Share

7.648

Quarterly Revenue Growth

0.042

The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Bio Retained Earnings from 2010 to 2025

Latest Bio Techne's Retained Earnings Growth Pattern

Bio Retained Earnings Regression Statistics

Bio Retained Earnings History

Other Fundumenentals of Bio Techne Corp

Bio Techne Retained Earnings component correlations

About Bio Techne Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY